Pharmaceutical Commerce - April 2025

View the Pharmaceutical Commerce April 2025 issue in an interactive format.

The April issue of Pharmaceutical Commerce examines the accelerated activity—and many ever-expanding layers—of temperature-sensitive transport in pharma.

One expert's take on reshoring pharma manufacturing services in the US amid likely tariffs to drugs looming.

Access USA converges in Philadelphia to explore new—and needed—solutions to boost patient outcomes.

Vendors are growing, and product and service offerings are expanding.

When delays and disruptions threaten not only product integrity but patient well-being, thorough risk assessment and mitigation are essential.

How artificial intelligence tools are helping to optimize the pharmaceutical transport process.

Exploring the importance of contract development and manufacturing organizations in advancing the latest technology for effective delivery of temperature-sensitive medicines.

The key strategies for reducing or eliminating post-prescription abandonment.

Why taking proactive steps—and combing the right data sources—is critical to informed decision-making in risk management.

A look at the prevailing factors impacting treatment access in 2025.

How pharma manufacturers can steadily navigate GTN components and complexities when planning pharmacy benefit reimbursement.

Respective industry and government agendas could significantly reshape the US prescription drug market.

Ensuring that essential treatments reach patients safely and efficiently is an increasing imperative in today's pharma landscape.

How data-driven insights can help pharma companies balance their revenue management and innovation strategies—including resource allocation, pricing, and market access.

Taking stock of today's gains and tomorrow's potential for generative artificial intelligence in reshaping the industry.